Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06329531 · ClinicalTrials.gov registry record

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

A clinical trial of Cancer and Occupational Therapy, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
80
Enrollment target
1
Study location

NCT06329531 is a study of Cancer and Occupational Therapy that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 80 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06329531, a study of Cancer and Occupational Therapy, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

To compare the results of the SOCS-OTS to another standardized screening measure that is currently being used by rehabilitation services at MD Anderson Cancer Center and to ensure that the SOCS-OTS correctly identifies those individuals needing OT services in cancer care.

Interventions

  • OTHER Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS)

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-07-12
Est. Completion 2027-12-01

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT06329531

The ClinicalTrials.gov registry entry for NCT06329531 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) is the first listed.

NCT06329531 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06329531 about?

NCT06329531 is a clinical study titled "Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic". To compare the results of the SOCS-OTS to another standardized screening measure that is currently being used by rehabilitation services at MD Anderson Cancer Center and to ensure that the SOCS-OTS correctly identifies those individuals needing OT services in cancer care.

What is the current status of trial NCT06329531?

This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2024-07-12. Estimated completion is 2027-12-01.

What conditions does trial NCT06329531 study?

This clinical trial studies the following conditions: Cancer, Occupational Therapy.

What interventions are being tested in trial NCT06329531?

The interventions under investigation include: Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) (OTHER).

Who is sponsoring clinical trial NCT06329531?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06329531 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.